Historique
Périodique
Behavioral naltrexone therapy: an integrated treatment for opiate dependance
(Thérapie comportementale à la naltrexone : un traitement intégré pour la dépendance aux opiacés)
Auteur(s) :
J. L. ROTHENBERG ;
M. A. SULLIVAN ;
S. H. CHURCH ;
A. SERACINI ;
E. COLLINS ;
H. D. KLEBER ;
E. V. NUNES
Article en page(s) :
351-360
Refs biblio. :
47
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Note générale :
Journal of Substance Abuse Treatment, 2002, 23, (4), 351-360
Note de contenu :
graph. ; tabl.
Résumé :
ENGLISH :
Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N= 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N= 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N= 29; 65% completed I month, 31 % completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted. (Editor's abstract.)
ENGLISH :
Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N= 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N= 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N= 29; 65% completed I month, 31 % completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted. (Editor's abstract.)
Affiliation :
New York State Psychiatric Inst., Div. Substance Abuse, Substance Treatment Res. Service, 1051 Riverside Drive, New York, NY 10032. E-mail : rothenbpi.cpmc.columbia.edu
Etats-Unis. United States.
Etats-Unis. United States.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |